ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZYME ZYMEWORKS INC (US)

Market Closed 10-02 16:00:00 EDT

25.15

-0.81

-3.12%

盘后25.15

+0.000.00%

19:30 EDT

High26.19	Low25.04	Vol844.45K
Open26.18	D1 Closing25.96	Amplitude4.43%
Mkt Cap1.78B	Tradable Cap1.68B	Total Shares70.96M
T/O21.41M	T/O Rate1.27%	Tradable Shares66.63M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ZYME","market":"US","secType":"STK","nameCN":"ZYMEWORKS INC (US)","latestPrice":25.15,"timestamp":1790971200000,"preClose":25.96,"halted":0,"volume":844446,"hourTrading":{"tag":"盘后","latestPrice":25.15,"preClose":25.15,"latestTime":"19:30 EDT","volume":267152,"amount":6718873.45,"timestamp":1790983804342,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.031201848998459254,"floatShares":66629700,"shares":70959200,"eps":-2.02,"marketStatus":"Market Closed","change":-0.81,"latestTime":"10-02 16:00:00 EDT","open":26.18,"high":26.19,"low":25.04,"amount":21408708.281466,"amplitude":0.044299,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.02,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1493352000000,"exchange":"NASDAQ","adjPreClose":25.96,"preHourTrading":{"tag":"盘前","latestPrice":26.72,"preClose":25.96,"latestTime":"09:28 EDT","volume":25,"amount":667.24,"timestamp":1790947680019,"change":0.76,"changeRate":0.029276,"amplitude":0.029276},"postHourTrading":{"tag":"盘后","latestPrice":25.15,"preClose":25.15,"latestTime":"19:30 EDT","volume":267152,"amount":6718873.45,"timestamp":1790983804342,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7200172303533996,"impliedVol":0.5153,"impliedVolPercentile":0.3307},"requestUrl":"/m/hq/s/ZYME","defaultTab":"news","newsList":[{"id":"2672197117","title":"Quince Therapeutics Names Leone Patterson Audit, Compensation Committee Chair in Board Overhaul","url":"https://stock-news.laohu8.com/highlight/detail?id=2672197117","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672197117?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:31","pubTimestamp":1790940669,"startTime":"0","endTime":"0","summary":"Quince Therapeutics names Leone Patterson audit, compensation committee chair in board overhaulQuince Therapeutics disclosed conditional resignations from directors June Bray, David Lamond, Christophe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLxklhw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1302929846.USD","LU1228905540.USD","INSM","LU0109394709.USD","LU1400636574.HKD","IE0034235071.USD","LU1015430645.USD","LU0971552830.HKD","LU0321505868.SGD","LU1645745479.HKD","LU1309081286.SGD","IE00BQJZX424.USD","LU0225284248.USD","LU0985481810.HKD","LU1400636491.USD","LU0889565916.HKD","LU1481600234.SGD","LU0306806265.USD","LU0203345920.USD","BK5011","LU2468319806.SGD","LU1064927863.SGD","LU0987226296.USD","LU1983299246.USD","BK4139","ZYME","QNCX","GSK.UK","LU0203347892.USD","LU0306807586.USD","LU0321505439.SGD","IE00BWDBJ516.SGD","LU0545562505.USD","LU0211331839.USD","LU1228905037.USD","LU0109981661.USD","SG9999001176.USD","LU1670756490.USD","IE00B3T34201.USD","LU1400636657.SGD","LU0161305163.EUR","LU0053671581.USD","LU0058720904.USD","LU0971552673.USD","LU1481599808.USD","LU0289739699.SGD","SG9999001176.SGD","LU0557290698.USD","LU1202635105.USD","LU1035777561.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752471","title":"Vir Biotechnology Names Aziz Sawaf as CFO Effective Oct. 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752471","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752471?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:31","pubTimestamp":1790857866,"startTime":"0","endTime":"0","summary":"Vir Biotechnology names Aziz Sawaf as CFO effective Oct. 5, 2026Vir Biotechnology appointed Aziz Sawaf as executive vice president and chief financial officer, effective Oct. 5, 2026.Sawaf will overse","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL7MZVyh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","BK4585","LU1037948897.HKD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU2357627491.SGD","BK4583","LU1674673691.USD","TBXU","GILD","LU0965509101.SGD","BK4588","IE0002270589.USD","LU0965508806.USD","IBB","SG9999015952.SGD","BK4532","LU2468319806.SGD","ZYME","VIR","SG9999015945.SGD","LU1061106388.HKD","LU2089984988.USD","LU1066053197.SGD","IE00B7SZLL34.SGD","LU0965509010.AUD","LU1066051498.USD","BK4578","BBH","BMED","LU2324357040.USD","LU2087621335.USD","LU0889565916.HKD","LU1430594728.SGD","LU0234570918.USD","LU0861579265.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1571399168.USD","BK4566","MEDI","TMED","BK4139","LU0058720904.USD","LU0859254822.USD","IBBQ","LU1778281490.HKD","LU0965509283.SGD","BIB","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671241988","title":"Zymeworks is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2671241988","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671241988?lang=en_us&edition=fundamental","pubTime":"2026-09-30 02:08","pubTimestamp":1790705280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZYME/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671248439","title":"Zymeworks Inc. : TD Cowen Reinstates Coverage with Buy Rating; Price Target $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671248439?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:35","pubTimestamp":1790692541,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671217785","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671217785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671217785?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:30","pubTimestamp":1790688638,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Summit Therapeutics (SMMT) and Zymeworks (ZYME) with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-361?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-361?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","HCSG","ZYME","XBI","BK4585","LU0128526141.USD","SMMT","BK4139","BK4137","BK4588","BK4581","LU2488822045.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671213864","title":"Zymeworks price target raised to $39 from $38 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2671213864","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671213864?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:50","pubTimestamp":1790675426,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Zymeworks (ZYME) to $39 from $38 and keeps a Buy rating on the shares. The firm says the close of the Therav...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-39-from-38-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-39-from-38-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236085","title":"Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236085","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236085?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:33","pubTimestamp":1790591626,"startTime":"0","endTime":"0","summary":"Zymeworks  said Monday it has completed its acquisition of Theravance Biopharma, adding Yupelri, a treatment for the long-term maintenance of chronic obstructive pulmonary disease, to its portfolio.The company said it expects 2026 revenue of $278 million to $292 million, including collaboration revenue from Yupelri.Yupelri, marketed through Theravance's partnership with Viatris, generated $133.1 million in sales in H1 2026. Zymeworks said it is entitled to 35% of net US profits from the drug and royalties on sales outside the US.The acquisition was financed with a $350 million non-recourse loan from OMERS Life Sciences and about $217.5 million of Zymeworks' cash.Zymeworks said it expects acquisition and restructuring-related costs of about $25 million to $30 million. It also expects a potential $100 million milestone payment related to Trelegy Ellipta in Q1 2027, subject to the milestone being met.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZYME","TBPH","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236348","title":"GUIDANCE: (ZYME) Zymeworks Expects 2026 Revenue Range $278M - $292M","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236348","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236348?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:11","pubTimestamp":1790590274,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ZYME) Zymeworks Expects 2026 Revenue Range $278M - $292M","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670949236","title":"Zymeworks announces financial impact of Theravance Biopharma acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2670949236","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670949236?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:10","pubTimestamp":1790590215,"startTime":"0","endTime":"0","summary":"The acquisition is expected to provide Zymeworks (ZYME) with meaningful and immediate incremental revenue and operating cash flow following closing...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-announces-financial-impact-of-theravance-biopharma-acquisition-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-announces-financial-impact-of-theravance-biopharma-acquisition-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBPH","ZYME","BK4585","SPHQ","BK4139","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670352312","title":"Zymeworks Inc. - Expects Total Revenue, Including Collaboration Revenue from Yupelri, for 2026 to be Between $278 Mln and $292 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2670352312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670352312?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:01","pubTimestamp":1790589668,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235228","title":"Zymeworks Inc. Fy2026 REV View $311.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670235228?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:01","pubTimestamp":1790589668,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I022:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670223235","title":"Zymeworks Outlook 2026 Adjusted Ebitda to be Between $114 Mln and $128 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2670223235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670223235?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:01","pubTimestamp":1790589668,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I022:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670419235","title":"Zymeworks Q2 FY26 Net Loss Widens to $45 Million; Revenue Guidance Rises to $278 Million-$292 Million for FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2670419235","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670419235?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:00","pubTimestamp":1790589639,"startTime":"0","endTime":"0","summary":"Zymeworks Q2 FY26 net loss widens to $45 million; revenue guidance rises to $278 million-$292 million for FY26Zymeworks reported a GAAP net loss of USD 45 million for the quarter ended June 30, 2026, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLbWH3dP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","NDAQ","TBPH","IE00BQXX3C00.GBP","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","BK4007","BCDF","SG9999014021.USD","BK4585","LU2095319765.USD","SG9999014039.USD","ZYME","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670914235","title":"Press Release: Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2670914235","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670914235?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:00","pubTimestamp":1790589600,"startTime":"0","endTime":"0","summary":"-- Acquisition diversifies durable cash flows and advances Zymeworks'. strategy to build a productive R&D company with a growing portfolio of. -- YUPELRI expected to contribute immediately accretive revenue and cash. -- Zymeworks to retain existing commercial organization supporting YUPELRI. -- The Company expects total revenue, including collaboration revenue from. YUPELRI, for 2026 to be between $278 million and $292 million and 2026. Adjusted EBITDA to be between $114 million and $128 million. -- Conference call with Zymeworks management today at 8:30 am Eastern Time","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLPA","BK4590","BK4585","ENFR","EMLP","SPHQ","USAI","MDST","TPZ","BK4022","BK4144","BK4007","BK4581","BK4561","UMI","TNGY","EIPI","R","BK4139","ZYME","AMZA","EIPX","TBPH","BK4588","BK4232","ET","AMLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669435098","title":"Zymeworks Completes Acquisition of Theravance Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2669435098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669435098?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:01","pubTimestamp":1790193660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA76DBCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668998710","title":"Zymeworks Initiated at Outperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2668998710","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668998710?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:12","pubTimestamp":1789654320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZYME/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961341","title":"Zymeworks initiated with an Outperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961341","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961341?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:20","pubTimestamp":1789644018,"startTime":"0","endTime":"0","summary":"Wolfe Research initiated coverage of Zymeworks (ZYME) with an Outperform rating. Published first on TheFly – the ultimate source for real-time, mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-initiated-with-an-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-initiated-with-an-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666996625","title":"Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666996625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666996625?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:30","pubTimestamp":1789047034,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0128526141.USD","BK4139","BK4505","XLV","LABU","BK4563","OCGN","BK4137","PTH","BK4581","BK4585","LU2324357040.USD","BK4007","BK4568","LU0029874061.USD","BK4588","AXSM","ZYME","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596964","title":"Theravance Biopharma Announces Shareholder Meeting on Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596964","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596964?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:11","pubTimestamp":1789045912,"startTime":"0","endTime":"0","summary":"Theravance Biopharma announces shareholder meeting on merger dealTheravance Biopharma shareholders will meet on Sept. 18, 2026 in South San Francisco, California.Vote scheduled on the proposed merger ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL8Lq0hz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007","ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745771","title":"Zymeworks (ZYME) Secures FDA Approval And $250 Million Milestone, Is The Stock Still Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745771","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745771?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:18","pubTimestamp":1787807892,"startTime":"0","endTime":"0","summary":"The latest move in Zymeworks (ZYME) stock comes after the U.S. FDA approved Ziihera, or zanidatamab hrii, for first line treatment of certain HER2 positive gastroesophageal cancers, triggering a US$250 million milestone from partner Jazz Pharmaceuticals.\nThe FDA decision appears to have reinforced investor confidence in Zymeworks, with the stock posting a 27.41% 1 month share price return and a 96.28% 1 year total shareholder return, while the 298.71% 3 year total shareholder return points to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/zymeworks-zyme-secures-fda-approval-and-250-million-mileston","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/zymeworks-zyme-secures-fda-approval-and-250-million-mileston","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","BK4139","LABU","ZYME"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zymeworks.com","stockEarnings":[{"period":"1week","weight":-0.0517},{"period":"1month","weight":-0.19},{"period":"3month","weight":-0.0441},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.4882},{"period":"ytd","weight":-0.0448}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.015488},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.056871},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.020874},{"month":4,"riseRate":0.666667,"avgChangeRate":0.045958},{"month":5,"riseRate":0.3,"avgChangeRate":0.007371},{"month":6,"riseRate":0.6,"avgChangeRate":-0.037508},{"month":7,"riseRate":0.4,"avgChangeRate":-0.043919},{"month":8,"riseRate":0.9,"avgChangeRate":0.127765},{"month":9,"riseRate":0.4,"avgChangeRate":0.024804},{"month":10,"riseRate":0.6,"avgChangeRate":0.03382},{"month":11,"riseRate":0.777778,"avgChangeRate":0.135367},{"month":12,"riseRate":0.555556,"avgChangeRate":0.004939}],"exchange":"NASDAQ","name":"ZYMEWORKS INC (US)","nameEN":"ZYMEWORKS INC (US)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ZYMEWORKS INC (US),ZYME,ZYMEWORKS INC (US)股票,ZYMEWORKS INC (US)股票老虎,ZYMEWORKS INC (US)股票老虎国际,ZYMEWORKS INC (US)行情,ZYMEWORKS INC (US)股票行情,ZYMEWORKS INC (US)股价,ZYMEWORKS INC (US)股市,ZYMEWORKS INC (US)股票价格,ZYMEWORKS INC (US)股票交易,ZYMEWORKS INC (US)股票购买,ZYMEWORKS INC (US)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}